Eric Paradise is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Executive Director, Oncology R&D Strategy at AstraZeneca since December 2018. With extensive experience in strategic leadership, Eric has previously held roles such as Head of Insights and Analytics for US Oncology, and Immuno-Oncology Franchise Strategy Head at MedImmune, where a cohesive investment framework was established across oncology portfolios. Eric's prior experiences include shaping early-stage partnering activities in therapeutic areas at MedImmune and strategic initiatives at Boston Consulting Group. Academic credentials include a Ph.D. in Chemical Engineering from the University of California, Berkeley, complemented by a B.S. in Chemical Engineering and Biochemistry from North Carolina State University.
This person is not in any teams
This person is not in any offices